FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera

FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for 
Treatment of Diarrhea in Cholera

World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4...
1 day ago
from: KXAN Austin

Continue reading...
Cholera, Crofelemer, Diarrhea, Food and Drug Administration, Jaguar Health, Orphan drug
More about this